These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. How useful are serum levels of cardiac drugs? Pennock RS Am Fam Physician; 1978 Apr; 17(4):194-6. PubMed ID: 645538 [No Abstract] [Full Text] [Related]
5. The pharmacology of cardio-active agents. Hayes AH Cardiovasc Clin; 1972; 4(3):103-18. PubMed ID: 4130206 [No Abstract] [Full Text] [Related]
6. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol. Kabra PM; Chen SH; Marton LJ Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493 [TBL] [Abstract][Full Text] [Related]
7. [Plasma concentrations of antiarrhythmic drugs (author's transl)]. Kasanuki H; Hirosawa K Kokyu To Junkan; 1977 May; 25(5):383-91. PubMed ID: 560038 [No Abstract] [Full Text] [Related]
8. Blood levels of drugs used in the treatment of cardiac arrhythmias. Kalman SM Clin Toxicol; 1978 Dec; 13(5):567-85. PubMed ID: 373974 [No Abstract] [Full Text] [Related]
9. Simultaneous determination of lidocaine, mexiletine, disopyramide, and quinidine in plasma by high performance liquid chromatography. Dusci LJ; Hackett LP J Anal Toxicol; 1985; 9(2):67-70. PubMed ID: 3990250 [TBL] [Abstract][Full Text] [Related]
10. Reliability of antiarrhythmic drug plasma concentration monitoring. Follath F; Ganzinger U; Schuetz E Clin Pharmacokinet; 1983; 8(1):63-82. PubMed ID: 6404580 [TBL] [Abstract][Full Text] [Related]
11. [Clinical--pharmacological problems of control--therapy with antiarrhythmic drugs (author's transl)]. Mazur M; Wisławska-Orłowska B Przegl Lek; 1978; 35(9):735-7. PubMed ID: 715260 [No Abstract] [Full Text] [Related]
12. High performance liquid chromatographic analysis of the antiarrhythmic drugs procainamide, disopyramide, quinidine, propranolol and metabolites from serum extracts. Wesley JF; Lasky FD Clin Biochem; 1981 Jun; 14(3):113-8. PubMed ID: 6170476 [TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography in the monitoring of plasma levels of antiarrhythmic drugs. Lagerström PO; Persson BA J Chromatogr; 1978 Feb; 149():331-40. PubMed ID: 649734 [TBL] [Abstract][Full Text] [Related]
14. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia. Hashimoto K; Satoh H; Shibuya T; Imai S J Pharmacol Exp Ther; 1982 Dec; 223(3):801-10. PubMed ID: 7143241 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of antiarrhythmia drugs by high-performance thin-layer chromatography. Lee KY; Nurok D; Zlatkis A J Chromatogr; 1978 Oct; 158():403-10. PubMed ID: 721938 [TBL] [Abstract][Full Text] [Related]
16. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782 [TBL] [Abstract][Full Text] [Related]
17. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. Nestico PF; Morganroth J Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932 [TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic drugs: clinical pharmacology and therapeutic uses. Anderson JL; Harrison DC; Meffin PJ; Winkle RA Drugs; 1978 Apr; 15(4):271-309. PubMed ID: 648399 [No Abstract] [Full Text] [Related]
19. Dosage regimens of antiarrhythmics. 1. Pharmacokinetic properties. Levy RH; Smith GH Am J Hosp Pharm; 1973 May; 30(5):398-404. PubMed ID: 4704419 [No Abstract] [Full Text] [Related]
20. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II. Singh BN; Cho YW; Kuemmerle HP Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721 [No Abstract] [Full Text] [Related] [Next] [New Search]